dc.contributor.author | Meniconi, M | |
dc.date.accessioned | 2020-06-29T09:59:46Z | |
dc.date.issued | 2018-03-15 | |
dc.identifier | PCT/US2017/050886 | |
dc.identifier | WO/2018/049296 | |
dc.identifier.citation | 2018 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/3788 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.title | HETEROARYL INHIBITORS OF PAD4 | |
dc.type | Patent | |
rioxxterms.licenseref.startdate | 2018-03-15 | |
rioxxterms.type | Other | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/In Silico Medicinal Chemistry | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/In Silico Medicinal Chemistry | |
pubs.embargo.terms | Not known | |
icr.researchteam | In Silico Medicinal Chemistry | en_US |
dc.contributor.icrauthor | Meniconi, Mirco | |